Metabolics Pharma: Latest News, Top Stories & Analysis

Metabolics Pharma’s ENT-03 Shows Promise in Obesity Treatment

June 30, 2025June 30, 2025 - by Timothy Alexander

DOYLESTOWN, PA — Metabolics Pharma has announced preclinical findings highlighting the unique benefits of its drug candidate, ENT-03, in treating obesity and related metabolic dysfunctions. The study revealed that ENT-03 …

Regional

Metabolics Pharma Reports Promising Phase 1a Results for ENT-03

June 28, 2025June 27, 2025 - by Timothy Alexander

DOYLESTOWN, PA — Metabolics Pharma has announced top-line results from a Phase 1a clinical trial of ENT-03, its investigational drug for obese and diabetic patients. The trial demonstrated that ENT-03 …